Literature DB >> 31987690

The science of vaccine safety: Summary of meeting at Wellcome Trust.

Stanley A Plotkin1, Paul A Offit2, Frank DeStefano3, Heidi J Larson4, Narendra Kumar Arora5, Patrick L F Zuber6, Eric Fombonne7, James Sejvar8, Paul Henri Lambert9, Anders Hviid10, Neal Halsey11, Nathalie Garçon12, Keith Peden13, Andrew J Pollard14, Lauri E Markowitz15, Jason Glanz16.   

Abstract

Vaccines are everywhere hugely successful but are also under attack. The reason for the latter is the perception by some people that vaccines are unsafe. However that may be, vaccine safety, life any other scientific subject, must be constantly studied. It was from this point of view that a meeting was organized at the Wellcome Trust in London in May 2019 to assess some aspects of vaccine safety as subjects for scientific study. The objective of the meeting was to assess what is known beyond reasonable doubt and conversely what areas need additional studies. Although the meeting could not cover all aspects of vaccine safety science, many of the most important issues were addressed by a group of about 30 experts to determine what is already known and what additional studies are merited to assess the safety of the vaccines currently in use. The meeting began with reviews of the current situation in different parts of the world, followed by reviews of specific controversial areas, including the incidence of certain conditions after vaccination and the safety of certain vaccine components. Lastly, information about the human papillomavirus vaccine was considered because its safety has been particularly challenged by vaccine opponents. The following is a summary of the meeting findings. In addition to this summary, the meeting organizers will explore opportunities to perform studies that would enlarge knowledge of vaccine safety.
Copyright © 2020.

Entities:  

Keywords:  Adjuvants; Autism; DNA; Encephalopathy; Safety

Year:  2020        PMID: 31987690     DOI: 10.1016/j.vaccine.2020.01.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes.

Authors:  Jason M Glanz; Christina L Clarke; Matthew F Daley; Jo Ann Shoup; Simon J Hambidge; Joshua T B Williams; Holly C Groom; Elyse O Kharbanda; Nicola P Klein; Lisa A Jackson; Bruno J Lewin; David L McClure; Stanley Xu; Frank DeStefano
Journal:  Pediatrics       Date:  2021-12-01       Impact factor: 9.703

Review 2.  Vaccine safety in the next decade: why we need new modes of trust building.

Authors:  Heidi J Larson; Isabelle Sahinovic; Madhava Ram Balakrishnan; Clarissa Simas
Journal:  BMJ Glob Health       Date:  2021-05

3.  Quadrivalent human papillomavirus vaccination and non-targeted infectious disease hospitalisation: Population-based self-controlled case series analysis.

Authors:  Anders Hviid; Anna Laksafoss
Journal:  Lancet Reg Health Eur       Date:  2021-08-28

Review 4.  The Vaccine-Hesitant Moment.

Authors:  Heidi J Larson; Emmanuela Gakidou; Christopher J L Murray
Journal:  N Engl J Med       Date:  2022-06-29       Impact factor: 176.079

Review 5.  Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation.

Authors:  Paul Löffler
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

6.  Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference.

Authors:  Dheeraj Soni; Simon D Van Haren; Olubukola T Idoko; Jay T Evans; Joann Diray-Arce; David J Dowling; Ofer Levy
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

Review 7.  Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Mario Boccadoro; Philippe Moreau; Jesus San-Miguel; Michele Cavo; Charlotte Pawlyn; Sonja Zweegman; Thierry Facon; Christoph Driessen; Roman Hajek; Melitios A Dimopoulos; Francesca Gay; Hervé Avet-Loiseau; Evangelos Terpos; Niklas Zojer; Mohamad Mohty; Maria-Victoria Mateos; Hermann Einsele; Michel Delforge; Jo Caers; Katja Weisel; Graham Jackson; Laurent Garderet; Monika Engelhardt; Niels van de Donk; Xavier Leleu; Hartmut Goldschmidt; Meral Beksac; Inger Nijhof; Niels Abildgaard; Sara Bringhen; Pieter Sonneveld
Journal:  Leukemia       Date:  2020-08-19       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.